Neutral impactResults
UltraTech Cement shares in focus as brokerages revise target prices after Q2 results. What Citi, Nomura, Jefferies say
Economic Times 1 hr ago·21 Oct 2026, 3:55 am
UltraTech Cement reported a strong 21% year-on-year rise in quarterly profit, prompting several leading brokerages to reassess their price targets for the stock. Nomura and Citi have lowered their target prices, while Jefferies has raised its estimate. Despite these adjustments, all three firms continue to maintain a 'Buy' rating on the company.
This divergence in analyst views highlights the ongoing debate regarding the stock's near-term valuation. For investors, the key takeaway is that the market is digesting the company's solid performance while weighing the impact of broader industry headwinds. The consensus remains positive, but the revised targets suggest some caution regarding immediate upside.
Investors should monitor the company's commentary on volume growth and operating margins in the coming quarters. The gap between the raised and lowered targets will be a critical factor to watch. A sustained uptick in volume traction could help bridge this gap and support the stock's current trajectory.
Excerpt from Economic Times
Shares of UltraTech Cement increased by 3% after the company reported strong quarterly earnings for Q2 FY27. The company's net profit saw a 21% growth compared to the previous year, driven by operational revenue increases. Jefferies raised its target price for the stock, indicating significant upside potential.…Read the original at Economic Times
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns UltraTech Cement (ULTRACEMCO).
- Category: Results.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for UltraTech Cement worth tracking. Use the price and stock snapshot to gauge how the market is responding.
